Cancer Imaging Program Fellowship

Unexpected openings for July 2022. Actively interviewing!

12mth PET/CT fellowship has been filled for 2022-23 and 2023-24

The Cancer Imaging Program (CIP) Fellowship at Brigham and Women’s Hospital/Dana-Farber Cancer Institute provides extensive experience in body imaging including MRI, CT, PET/CT, and US in adult patients with cancer. Dana-Farber Cancer Institute (DFCI) is a Harvard Medical School Teaching affiliate and provides adult clinical care jointly with Brigham and Women’s Hospital.  

Rotation Overview: 

• • Depending on chosen track, General or PET-CT imaging, time will be spent reading cancer imaging studies with our CT, MR or U/S (General track) or PET-CT (PET-CT 3- or 12mth tracks).
  • Approximately 10-20% of the fellow’s time can be dedicated to research assuming that a detailed research project outline has been presented and approved by an attending radiologist as the project mentor. Research milestone schedules are clearly articulated, and research progress is closely monitored. Research time to begin 2 months after start of fellowship and contingent on clinical coverage.
  • Four weeks of the CIP fellowship is designated elective time. Elective time may be spent on approved research projects, or in other radiology disciplines elsewhere.
  • Coverage responsibilities also include rotating weekend day coverage at Longwood campus and weekday coverage at Chestnut Hill campus.

Eligibility:

U.S. applicants must be board-eligible or board-certified in radiology. Foreign applicants must be ECFMG certified and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at DFCI is structured in accordance with the fellowship regulations as provided by the Department of Radiology at BWH.

Teaching/Conference Responsibilities:

There is a weekly seminar series designated for Category 1 CME credit, including introductory and modality-based lectures and disease-centric “blocks” thereafter. Other educational activities include a weekly radiology-pathology conference, drug conferences and MRI/CT case conferences. These are in addition to continual one-on-one teaching throughout the day.

Fellowship Supervision and Evaluation:

Cancer Imaging Fellows will receive continuous on-site training, teaching and feedback. Dr. Lauren Roller, Program Director of the Cancer Imaging Fellowship Program and  the Chief of the Department of Imaging, DFCI, will evaluate the fellow’s performance.

Equipment and Resources:

State-of-the-art equipment includes 64-slice CT, 1.5-T and 3-T MRI, PET/CT, digital radiography, Hologic digital tomosynthesis mammography, Philips IU22 ultrasound, GE LOGIQ E9 XDclear 2.0 ultrasound, and gamma camera systems.

Applicants can upload their C.V., Personal statement, photograph, USMLE scores and reference contact information at https://form.jotform.com/BWHRadRes/DFCI_CancerImagingApplication  Canadian Physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE and COMLEX examinations. Other foreign applicants must send ECFMG certification. We seek applicants of diverse backgrounds, which we believe truly enriches the training environment

Lauren Roller, MD, Cancer Imaging Fellowship Program Director

Dana-Farber Cancer Institute, Department of Imaging

450 Brookline Ave, Boston MA 02215

Attention: Ashley Watterson, Room DL-198

TEL: (617) 632-4891; FAX: (617) 582-8574

E-mail: CancerImagingFellowship@DFCI.Harvard.edu